Results 221 to 230 of about 136,379 (287)

Acquired cystic disease-associated renal cell carcinoma: a case report. [PDF]

open access: yesAnn Med Surg (Lond)
Tao J, Pan W, JunHui Z, BingQuan L.
europepmc   +1 more source

Papillary renal cell carcinoma: Review

Urologic Oncology: Seminars and Original Investigations, 2021
Kidney cancer is the 13th most common malignancy globally, and the incidence is rising. Papillary renal cell carcinoma is the second most common subtype, comprising 10-15% of renal cell carcinomas. Though the histologic features of this subtype were initially described in the 1990's, our understanding of the genetic and molecular characteristics of ...
Neil, Mendhiratta   +3 more
openaire   +2 more sources

NF2-mutated Renal Carcinomas Have Common Morphologic Features Which Overlap With Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma

American Journal of Surgical Pathology, 2022
Genetic alterations involving NF2 occur at low frequencies in renal cell carcinoma across all of the major histologic subtypes and have been associated with adverse outcomes.
A. Paintal   +8 more
semanticscholar   +1 more source

Hereditary Papillary Renal Cell Carcinoma

Journal of Urology, 1994
We describe a 3 generation family with members affected with papillary renal cell carcinoma, an uncommon histological type of renal cell carcinoma. Multiple tumors of varying size were present in both kidneys of affected family members. The disorder was not linked to polymorphic markers on chromosome 3p and there was no loss of heterozygosity at loci ...
B, Zbar   +8 more
openaire   +2 more sources

Papillary Renal Cell Carcinoma

2018
Papillary renal cell carcinoma (pRCC) is the second most common subtype of kidney cancer after clear cell renal cell carcinoma (ccRCC) and accounts for approximately 15–20% of renal malignancies [1, 2]. The term papillary RCC is a histologic designation, and the diagnosis is based on the presence of papillary or tubulopapillary structures on ...
Ramaprasad Srinivasan, Kai Hammerich
openaire   +2 more sources

Home - About - Disclaimer - Privacy